Direkt zum Inhalt
Merck
  • Effects of lifestyle modifications on cognitive impairments in a mouse model of hypercholesterolemia.

Effects of lifestyle modifications on cognitive impairments in a mouse model of hypercholesterolemia.

Neuroscience letters (2013-03-09)
Eduardo Luiz Gasnhar Moreira, Aderbal S Aguiar, Cristiane Ribeiro de Carvalho, Danúbia Bonfanti Santos, Jade de Oliveira, Andreza Fabro de Bem, João Carlos Xikota, Roger Walz, Marcelo Farina, Rui Daniel Prediger
ZUSAMMENFASSUNG

Epidemiological studies indicate that high midlife plasma cholesterol levels increases the risk of Alzheimer's disease. Moreover, middle-aged familial hypercholesterolemia (FH) subjects show a particularly high incidence of mild cognitive impairments (MCI). These evidence points to hypercholesterolemia as one of the modifiable risk factors focused on prevention/treatment of cognitive deterioration. The present study draws a comparison between pharmacological (lipid-lowering drug probucol) and non-pharmacological (voluntary running wheel, RW) approaches for the management of hypercholesterolemia and cognitive impairments associated with the low-density lipoprotein receptor-deficient (LDLr(-/-)) mice, a well-established rodent model of FH. We also investigated whether exposure to environmental enrichment (EE), a feasible option to increase physical activity in young mice cohort, from birth to adolescence (PN45) yields long-term behavioral changes in adult LDLr(-/-) mice (PN90). We observed that both probucol and RW significantly decreased total and non-HDL plasma cholesterol levels in LDLr(-/-) mice. Notably, only physical exercise mitigated the spatial memory deficits of LDLr(-/-) mice. In addition, we showed that exposure to EE from birth until the adolescence did not mitigate the spatial memory deficits of adult LDLr(-/-) mice in the object location task, although it induced persistent anxyolitic-like effects in the open field arena. Collectively, our results emphasize the advantages physical exercise, in comparison to lipid-lowering drugs, for the management of cognitive deficits associated with FH.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Probucol, analytical standard